Correlation Between Citigroup and Standard Chemical
Can any of the company-specific risk be diversified away by investing in both Citigroup and Standard Chemical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Citigroup and Standard Chemical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Citigroup and Standard Chemical Pharmaceutical, you can compare the effects of market volatilities on Citigroup and Standard Chemical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Citigroup with a short position of Standard Chemical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Citigroup and Standard Chemical.
Diversification Opportunities for Citigroup and Standard Chemical
-0.46 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Citigroup and Standard is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Citigroup and Standard Chemical Pharmaceutic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Standard Chemical and Citigroup is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Citigroup are associated (or correlated) with Standard Chemical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Standard Chemical has no effect on the direction of Citigroup i.e., Citigroup and Standard Chemical go up and down completely randomly.
Pair Corralation between Citigroup and Standard Chemical
Taking into account the 90-day investment horizon Citigroup is expected to generate 2.93 times more return on investment than Standard Chemical. However, Citigroup is 2.93 times more volatile than Standard Chemical Pharmaceutical. It trades about 0.01 of its potential returns per unit of risk. Standard Chemical Pharmaceutical is currently generating about -0.01 per unit of risk. If you would invest 6,991 in Citigroup on December 30, 2024 and sell it today you would earn a total of 42.00 from holding Citigroup or generate 0.6% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 91.94% |
Values | Daily Returns |
Citigroup vs. Standard Chemical Pharmaceutic
Performance |
Timeline |
Citigroup |
Standard Chemical |
Citigroup and Standard Chemical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Citigroup and Standard Chemical
The main advantage of trading using opposite Citigroup and Standard Chemical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Citigroup position performs unexpectedly, Standard Chemical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Standard Chemical will offset losses from the drop in Standard Chemical's long position.Citigroup vs. PJT Partners | Citigroup vs. National Bank Holdings | Citigroup vs. FB Financial Corp | Citigroup vs. Northrim BanCorp |
Standard Chemical vs. Sinphar Pharmaceutical Co | Standard Chemical vs. Grape King Bio | Standard Chemical vs. Apex Biotechnology Corp | Standard Chemical vs. Maywufa Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |